In vitro study demonstrates that strontium- and magnesium-doped octacalcium phosphate modulates immune cell activation in THP-1 models, suggesting a balanced profile for bone regeneration.
The development of modern osteoplastic materials with controlled immunomodulatory properties represents a critical objective in bone tissue engineering. Octacalcium phosphate (OCP) serves as a promising precursor to bone apatite; however, its clinical application is limited by inconsistent biological response for recipients with similar nosology. Ionic doping presents a prospective approach for enhancing the functional characteristics of calcium phosphates. This study is dedicated to the synthesis and in vitro investigation of the immunomodulatory effects of low-temperature OCP co-doped with Sr²⁺/Mg²⁺ and Sr²⁺/Ba²⁺. The developed materials were characterized using X-ray diffraction (XRD) and Fourier-transform infrared spectroscopy (FTIR). The incorporation of strontium during OCP synthesis was shown to destabilize the crystal lattice and reduce crystallite size. In vitro studies utilizing monocyte-like (THP-1 ATRA) and macrophage-like (THP-1 PMA) cell models demonstrated that the doped OCP materials did not induce cytotoxic effects and effectively modulated the functional activity of immune cells. Specifically, in monocyte-like cells, both OCP materials enhanced phagocytic activity and significantly increased the secretion of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6). In macrophage-like cells, the materials reduced phagocytic activity and exerted dual ion-dependent effects on reactive oxygen species (ROS) production. Furthermore, they stimulated cytokine secretion predominantly under non-inflammatory conditions. Notably, OCP_Sr20_Mg1 induced a comparatively milder proinflammatory response compared to OCP_Sr20_Ba1, specifically reducing ROS formation and cytokine secretion by monocyte-like and macrophage-like cells under standard conditions. These results suggest that Sr/Mg co-doping may provide a more balanced immunomodulatory profile favorable for osteoplastic applications. The findings indicate that the immunomodulatory effect is likely mediated through direct particle-cell interactions influencing intracellular processes such as phagocytosis and lysosomal activity, rather than being solely attributable to soluble ion release.
No takes yet. Share an insight, caveat, or question.
Minaichev et al. (2026) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: